Evidence map›Paper›PMID 25028717›Full record

ArticleScience signaling2014

The E3 ligase PARC mediates the degradation of cytosolic cytochrome c to promote survival in neurons and cancer cells.

Vivian Gama, Vijay Swahari, Johanna Schafer, Adam J Kole, Allyson Evans, Yolanda Huang, Anna Cliffe, Brian Golitz, Noah Sciaky, Xin-Hai Pei and 2 more

Abstract read
In one paragraph

Article in Science signaling, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Long-Term Exposure to Nanosized TiOInternational journal of molecular sciences · 2021
    Article
  19. Membrane Depolarization Inhibits BIMMolecular neurobiology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Vivian GamaNeuroscience Center, University of North Carolina, Chapel Hill, NC 27599, USA. Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC 27599, USA.
Vijay SwahariNeuroscience Center, University of North Carolina, Chapel Hill, NC 27599, USA. Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC 27599, USA.
Johanna SchaferNeuroscience Center, University of North Carolina, Chapel Hill, NC 27599, USA.
Adam J KoleDepartment of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC 27599, USA.
Allyson EvansDepartment of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC 27599, USA.
Yolanda HuangDepartment of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC 27599, USA.
Anna CliffeNeuroscience Center, University of North Carolina, Chapel Hill, NC 27599, USA. Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC 27599, USA.
Brian GolitzUNC RNAi Screening Facility, University of North Carolina, Chapel Hill, NC 27599, USA. Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599, USA.
Noah SciakyUNC RNAi Screening Facility, University of North Carolina, Chapel Hill, NC 27599, USA. Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599, USA.
Xin-Hai PeiLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA. Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC 27599, USA.
Yue XiongLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA. Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC 27599, USA.
Mohanish DeshmukhNeuroscience Center, University of North Carolina, Chapel Hill, NC 27599, USA. Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC 27599, USA. Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA. mohanish@med.unc.edu.
University of North Carolina at Chapel Hill · USUNC Lineberger Comprehensive Cancer Center

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
UNC Neuroscience Center Research Cores: MicroscopyP30NS045892 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZYLKA, MARK J. · 2003 to 2022
$11.5M
The Physiological Function and Regulation of INK4 GenesR01CA068377 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MARZLUFF, WILLIAM F. · 1995 to 2021
$6.5M
The ROC-Cullin Family of E3 Ubiquitin LigasesR01GM067113 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI XIONG, YUE · 2003 to 2019
$5.4M
Cytochrome c Degradation: A Mechanism to Restrict Apoptosis in Postmitotic CellsR01GM078366 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DESHMUKH, MOHANISH P · 2006 to 2013
$2.6M
NCI NIH HHS P30 CA016086NCI NIH HHS R01 CA068377NIGMS NIH HHS GM078366NIGMS NIH HHS R01 GM067113NIGMS NIH HHS R01 GM078366NINDS NIH HHS P30 NS045892NINDS NIH HHS P30 NS04892
6 · The paper itself

Abstract

The ability to withstand mitochondrial damage is especially critical for the survival of postmitotic cells, such as neurons. Likewise, cancer cells can also survive mitochondrial stress. We found that cytochrome c (Cyt c), which induces apoptosis upon its release from damaged mitochondria, is targeted for proteasome-mediated degradation in mouse neurons, cardiomyocytes, and myotubes and in human glioma and neuroblastoma cells, but not in proliferating human fibroblasts. In mouse neurons, apoptotic protease-activating factor 1 (Apaf-1) prevented the proteasome-dependent degradation of Cyt c in response to induced mitochondrial stress. An RNA interference screen in U-87 MG glioma cells identified p53-associated Parkin-like cytoplasmic protein (PARC, also known as CUL9) as an E3 ligase that targets Cyt c for degradation. The abundance of PARC positively correlated with differentiation in mouse neurons, and overexpression of PARC reduced the abundance of mitochondrially-released cytosolic Cyt c in various cancer cell lines and in mouse embryonic fibroblasts. Conversely, neurons from Parc-deficient mice had increased sensitivity to mitochondrial damage, and neuroblastoma or glioma cells in which PARC or ubiquitin was knocked down had increased abundance of mitochondrially-released cytosolic Cyt c and decreased viability in response to stress. These findings suggest that PARC-mediated ubiquitination and degradation of Cyt c is a strategy engaged by both neurons and cancer cells to prevent apoptosis during conditions of mitochondrial stress.

Indexed as

AnimalsApoptotic Protease-Activating Factor 1Blotting, WesternCarrier ProteinsCells, CulturedCell SurvivalCytochromes cFluorescent Antibody TechniqueHEK293 CellsHeLa CellsHumansImmunoprecipitationMiceMitochondrial DiseasesNeoplasmsNeuronsApaf1 protein, mouseApoptotic Protease-Activating Factor 1Carrier ProteinsCul9 protein, humanCytochromes cTransferases

Identifiers

PMID25028717
PMCPMC4182917
OpenAlexW2148704130

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.